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Lymphoma of the mucosa-associated lymphoid tissue (MALT), as
introduced by Isaacson and Wright in the early 1980s, is a distinct
clinicopathologic entity with characteristic histologic features
(Isaacson and Wright, 1983). The MALT lymphoma concept
suggests that these tumours, which may be of low- or high-grade
malignancy, correspond to cells of postfollicular differentiation
stages (Qin et al, 1995) and usually arise in the background of
chronic antigenic stimulation triggered by persistent infections
and/or autoimmune processes (Greiner et al, 1994). The majority
of MALT-type lymphomas occur in the stomach, but this type of
lymphoma may affect virtually every organ in the human body,
including the intestine, salivary glands, thyroid, lung and ocular
adnexa, but also, though less frequently, the skin, urinary bladder
and the gonads (Zucca et al, 1997; Isaacson and Norton, 1994a).
MALT-type lymphomas usually exhibit a tendency to remain
localized within the affected MALT-organ for a prolonged period
of time, resulting in a favourable prognosis as compared to nodal
lymphomas (Thieblemont et al, 1997).
The sites at which MALT-type lymphomas arise are usually
devoid of lymphoid tissue, however, chronic antigenic stimulation
may induce the accumulation of MALT which prepares the back-
ground for the development of MALT-type lymphoma. Activated
normal mucosal lymphocytes preferentially recirculate to the
mucosa (‘homing’) by binding of their surface receptor a4b7 to
the respective ligand on mucosal venule endothelium (Berlin et al,
1993). Similar traffic-control mechanisms appear to be operative
also in MALT-type lymphoma, as recently demonstrated in a case
of primary gastric lymphoma with secondary intestinal spread
(Isaacson and Norton, 1994a; 1994b; Isaacson, 1999). Since
dissemination within MALT may occur without generating overt
clinical manifestations, thorough staging of patients to rule out
multifocal involvement before initiation of therapy seems manda-
tory once MALT-type lymphoma has been diagnosed.
This is especially important in view of the fact that individual
forms of treatment such as eradication of Helicobacter pylori
(HP), radiation or chemotherapy are appropriate in different stages
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Lymphoma of the mucosa-associated lymphoid tissue (MALT) type usually arises in MALT acquired through chronic antigenic stimulation
triggered by persistent infection and/or autoimmune processes. Due to specific ligand–receptor interactions between lymphoid cells and high-
endothelial venules of MALT, both normal and neoplastic lymphoid cells display a pronounced homing tendency to MALT throughout the body.
In the case of neoplastic disease these homing properties may be responsible for lymphoma dissemination among various MALT-sites.
According to this concept, we have standardized staging procedures in all patients diagnosed with MALT-type lymphoma. All patients with
MALT-type lymphoma underwent standardized staging procedures before treatment. Staging included ophthalmologic examination,
otolaryngologic investigation, gastroscopy with multiple biopsies, endosonography of the upper gastrointestinal tract, enteroclysis,
colonoscopy, computed tomography of thorax and abdomen and bone marrow biopsy. Biopsy was performed in all lesions suggestive for
lymphomatous involvement, and evaluation of all biopsy specimens was performed by a reference pathologist. 35 consecutive patients with
histologically verified MALT-type lymphoma were admitted to our department. Twenty-four patients (68%) had primary involvement of the
stomach, five (15%) had lymphoma of the ocular adnexa, three (8.5%) had lymphoma of the parotid, and three (8,5%) of the lung. Lymph-
node involvement corresponding to stage EII disease was found in 13 patients (37%), only one patient with primary gastric lymphoma had
local and supradiaphragmatic lymph-node involvement (stage EIII). Bone marrow biopsies were negative in all patients. Overall, eight of 35
patients (23%) had simultaneous biopsy-proven involvement of two MALT-sites: one patient each had lymphoma of parotid and lacrimal
gland, conjunctiva and hypopharynx, conjunctiva and skin, lacrimal gland and lung, stomach and colon, and stomach and lung. The remaining
two patients had bilateral parotideal lymphoma. Staging work-up was negative for lymph-node involvement in all of these eight patients. The
importance of extensive staging in MALT-type lymphoma is emphasized by the demonstration of multiorgan involvement in almost a quarter
of patients. In addition, our data suggest that extra-gastrointestinal MALT-type lymphoma more frequently occurs simultaneously at different
anatomic sites than MALT-type lymphoma involving the GI-tract. © 2000 Cancer Research Campaign
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et al, 1998), and therefore strongly depend on meticulous perfor-
mance of exact staging. In fact, synchronous MALT-type
lymphoma at different sites has repeatedly been reported, as has
the propensity for late relapse even after decades in patients under-
going local treatment after initial diagnosis (Kawamata et al, 1995;
Grazade et al, 1998; Stephen et al, 1998). As MALT may be
acquired in several organs, pre-therapeutic work-up as well as
follow-up should be quite extensive. We have therefore standard-
ized staging procedures for patients with MALT-type lymphoma at
our department and present the results obtained with this extensive
staging routine between January 1997 and January 1999.
PATIENTS AND METHODS
Between January 1997 and January 1999, 35 patients with a histo-
logically verified diagnosis of MALT-type lymphoma were
admitted to our department. Upon admission, all biopsy specimens
obtained were evaluated by a reference pathologist to verify the
presence of MALT-type lymphoma before initiation of staging.
Histologic diagnosis of low-grade lymphoma of MALT-type was
performed according to the criteria outlined by Isaacson (Isaacson
1983; Isaacson and Norton, 1994a). In addition, immunologic
phenotyping on paraffin sections was done for demonstration of
light-chain restriction and the phenotype CD20+CD5–CD10-
cyclinD1-which, in context with the microscopic appearance, is
consistent with low-grade B-cell lymphoma of MALT-type. The
diagnosis of high-grade lymphoma was based on the presence of
large cells with blastic appearance growing in sheets often
between glands, with or without a low-grade component, and was
also confirmed by phenotyping. In patients with a predominance
of a large-cell component, the presence of a low-grade component
defined the MALT-origin of the lymphoma, and also pure large-
cell lymphomas (diffuse large-cell lymphomas) without evidence
of extragastric spread beyond contiguous lymph nodes were
included. While the presence of primary diffuse large-cell
lymphoma without a low-grade background is not unequivocally
felt to be pathogenetically related to MALT-type lymphoma (Chan
et al, 1998), cytological and clinical features of such lymphomas
arising within a low-grade background are similar to those lesions
without a low-grade component. Thus, for the time being, it
appears reasonable to classify the latter as primary high-grade
MALT-type lymphomas (Isaacson and Norton, 1994a; 1994b;
Isaacson, 1999), and these patients were also included in our
series.
All patients diagnosed with MALT-type lymphoma underwent
extensive staging before initiation of therapy. Staging consisted 
of ophthalmologic examination, otolaryngologic investigation
including sonography of the salivary glands or magnetic resonance
imaging if indicated, gastroscopy with multiple biopsies,
endosonography of the upper GI-tract, enteroclysis, colonoscopy,
and bone marrow biopsy. CT-scans were evaluated by a reference
radiologist, and endoscopies and endosonography were performed
by a single individual, as was otolaryngologic examination to rule
out inter-observer variabilities. In case of lesions suggestive for
lymphomatous involvement, biopsy was attempted in all cases,
and all biopsy specimens were again evaluated by a reference
pathologist. Staging was performed according to the Ann Arbor
staging system modified by Mushoff (1977).
RESULTS
Among this series of 35 patients (Figure 1), the stomach was the
initial site of disease upon diagnosis in 24 patients (68%). Eleven of
these patients each had low-grade MALT-type lymphoma or high-
grade lymphoma, while two had high-grade disease arising within a
low-grade component. Eleven of the 35 patients (32%) had primary
extragastric MALT-type lymphoma, occurring in the ocular adnexa
(n = 5), the parotid gland (n = 3) and the lung (n = 3).
Staging work-up revealed nodal involvement in 14 of the 35
patients (43%), 13 had stage EII disease and one patient with
gastric lymphoma had enlarged lymph nodes on both sides of the
diaphragm (stage EIII). In 12 of the patients with stage EII disease,
lymph-node enlargement was identified both by CT scan and
endosonography, and afflicted lymph nodes were identified by
endosonography in one patient. In the patient with stage EIII
disease, spiral CT-scan showed enlarged lymph nodes on both
sides of the diaphragm, while conventional chest X-ray was not
suggestive of enlarged lymph nodes.
In total, eight patients of 35 (23%) had involvement of at least
two MALT-organs as documented by staging and consecutive
histology (Figure 1). Two patients with primary low-grade gastric
MALT-type lymphoma were found to have multifocal disease,
involving colon and lung, respectively. Histologic examination of
the biopsy samples obtained during colonoscopy and fine-needle
biopsy of the lung showed low-grade MALT-type lymphoma
corresponding to the histology seen in the gastric lesion. No
patient with primary high-grade gastric lymphoma had evidence of
multiorgan involvement.
A relatively high proportion of multifocal disease, however, was
found in patients with extragastric primaries. In four patients
presenting with initial MALT-type lymphoma of the ocular adnexa
(located in the conjunctiva and the lacrimal gland in two patients
each), synchronous involvement of skin, hypopharynx, parotid and
lung was discovered. Again, biopsies obtained from these lesions
disclosed low-grade MALT-type lymphoma. In the patient with
involvement of both conjunctiva and hypopharynx, the presence of
a CD5+ MALT-type lymphoma was disclosed in both locations. In
addition, two patients were found to have bilateral MALT-type
lymphoma of the parotid as diagnosed by MRI after superficial
unilateral parotidectomy in both cases, and was subsequently veri-
fied by contralateral biopsy.
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DISCUSSION
MALT-type lymphoma is a relatively rare disease, but nevertheless
represents the third most common lymphoma type, accounting for
about 7% of all non-Hodgkin’s lymphomas (Pileri et al, 1998).
Recent years have seen major advances in uncovering a causative
role of HP in gastric MALT-type lymphoma along with the poten-
tial for complete disappearance of lymphoma after successful
eradication of HP in patients with low-grade disease (Isaacson,
1999; Roggerc et al, 1995). According to the recent literature,
however, benefit from HP-eradication as sole management seems
to be restricted to patients with early-stage disease confined to
mucosa and submucosa. In addition, promising results have been
reported with application of local radiotherapy in patients with
localized lymphoma (Schechter et al, 1998), which would never-
theless result in undertreatment of patients with disseminated
disease.
The propensity for mucosal generalization of MALT-type
lymphoma has repeatedly been extrapolated from reports demon-
strating distant mucosal relapse years after successful local treat-
ment for MALT-type lymphoma (Stephen et al, 1998; Kawamata
et al, 1995). In addition, pathologic investigations have clearly
shown multifocal involvement of the gastric mucosa in all gastrec-
tomy specimens investigated by PCR (Wotherspoon et al, 1992;
Sackmann et al, 1997; Du et al, 1999) even in the absence of clini-
cally and histologically detectable intragastric dissemination.
However, the exact percentage of patients affected by clinically
apparent multiorgan disease upon diagnosis is not known in detail,
as is the risk of relapse within MALT after treatment. Our series
allows a rough estimation of the risk for multiorgan involvement
in patients diagnosed with MALT-type lymphoma and clearly
underscores the importance of extensive staging. Overall, multi-
organ involvement was found in almost a quarter of patients (eight
of 35) admitted at our institution in a 2-year interval. None of these
eight patients, however, had lymph-node involvement, which was
detected in a total of 14 patients (43%).
Interestingly only two of 24 patients with gastric MALT-type
lymphoma were found to have multifocal disease, whereas six of
11 patients (55%) with extragastric primary manifestations were
identified to have synchronous involvement of different anatomic
sites, including two patients with bilateral parotid lymphoma.
While the occurrence of bilateral parotid lymphoma has repeatedly
been described and might be rated as multifocal involvement
within the same organ as also seen in gastric MALT-type
lymphoma, we could also demonstrate involvement of both the
parotid and the contralateral lacrimal gland in one patient.
In addition, no case of multiorgan disease could be found among
high-grade lymphoma patients, again raising the question about
pathogenetic differences between these lymphomas and MALT-
lymphomas without a high-grade component.
Our data suggest a relatively high rate of multiorgan involve-
ment in non-gastric MALT-type lymphomas as opposed to MALT-
lymphoma involving the gastrointestinal tract. However, one
might argue that these data are the result of a diagnostic bias due to
easier accessibility of extra-intestinal MALT-organs such as ocular
adnexa or parotid as compared to the GI-tract, resulting in a
different latency to clinical manifestation and diagnosis. Recent
findings nevertheless indicate putative regionalization in circula-
tion of lymphoid cells between different MALT-sites (Brandtzaeg
et al, 1999), providing the cellular and molecular basis for our
clinical findings. In fact, lymphoid cells derived from extra-
intestinal MALT prefer to circulate through mucosae outside the
GI-tract, whereas the opposite applies to GI-MALT, where
lymphoid cells possess a low affinity for non-GI MALT
(Brandtzaeg et al, 1999).
Taken together, a standardized staging procedure as performed
in our series (Table 1) seems mandatory before initiation of
therapy in patients with MALT-type lymphoma in general and in
patients with extra-gastrointestinal MALT lymphoma in particular.
Demonstration of multiorgan involvement appears to be an impor-
tant clinical information before initiation of therapy, since such
patients are unlikely to benefit from local therapy such as irradia-
tion in extra-gastric sites, and to the current knowledge are not
suitable candidates for eradication of HP as sole treatment
modality in case of gastric origin of the lymphoma.
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